MedPath

山西惠达林曦医药科技有限公司

Ownership
-
Established
2021-09-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20253452
Approval Date
Feb 25, 2025
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20253216
Approval Date
Jan 14, 2025
NMPA

Levocetirizine Dihydrochloride Oral Drops

Product Name
盐酸左西替利嗪口服滴剂
Approval Number
国药准字H20244302
Approval Date
Jun 28, 2024
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath